Head and neck cancer trials in Poland
20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingResearch participation
LYSARI – LYmphocyte-Sparing And Radio-Immunotherapy in Head and neck carcinoma - A multicenter, randomised 2*2 factorial design comparing standard to reduced-target volume radiotherapy with or without all-trans retinoic acid (ATRA) in patients with lateralised oropharyngeal, laryngeal and hypopharyngeal squamous cell carcinoma.
- Where
- Gliwice, Poznan
- Age
- 18 years and over
- People
- 630 worldwide
- Run by
- Centre Leon Berard
See details and how to join2022-501315-13-00EU 2022-501315-13-00Registry updated 2026-11-05
Phase 1/2RecruitingTrial-stage medicine
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Where
- Gdansk, Gliwice, Warsaw
- Age
- 18 years and over
- People
- 287 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06385080EU 2023-508418-40-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Where
- Gdansk, Gliwice, Lodz, Lublin, Poznan, Warsaw
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07276399EU 2025-521917-24-00Registry updated 2026-11-03
Phase 2/3RecruitingTrial-stage medicine
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Where
- Bydgoszcz, Cracow, Gdansk, Gliwice, Katowice, Konin, Siedlce, Warsaw
- Age
- 18 years and over
- People
- 650 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT06788990EU 2024-519654-37-00Registry updated 2026-10-29
Phase 2RecruitingTrial-stage medicine
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Cracow
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089EU 2025-523895-22-00Registry updated 2026-10-29
Phase 2/3RecruitingTrial-stage medicine
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
- Where
- Gliwice, Konin, Piotrkow Trybunalski
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT06295731Registry updated 2026-10-28
Phase 1/2RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Cracow, Lodz, Rzeszów, Siedlce, Skorzewo
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064EU 2023-509632-26-00Registry updated 2026-10-26
Phase 2RecruitingTrial-stage medicine
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Przemyśl
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06769698EU 2024-517620-19-00Registry updated 2026-10-22
Phase 2RecruitingTrial-stage medicine
A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
- Where
- Gliwice, Siedlce, Warsaw
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT07807163EU 2026-526741-10-00Registry updated 2026-10-13
Phase 1RecruitingTrial-stage medicine
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483EU 2023-510061-10-00Registry updated 2026-10-01
Phase 3RecruitingTrial-stage medicine
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- Where
- Bialystok, Bielsko-Biala, Bydgoszcz, Gliwice, Olsztyn, Piotrkow Trybunalski, Siedlce, Tomaszów Mazowiecki, Warsaw
- Age
- 18 years to 130 years
- People
- 1,145 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06129864Registry updated 2026-09-30
Phase 1/2RecruitingTrial-stage medicine
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
- Where
- Gdansk, Gliwice, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- Nykode Therapeutics ASA
See details and how to joinNCT06016920EU 2022-503055-26-00Registry updated 2026-08-26
No phaseEnrolling by invitationResearch participation
The Importance of Mucosal Screening in the Prevention of Oral Cancer.
- Where
- Warsaw
- Age
- 18 years and over
- People
- 1,383
- Run by
- Medical University of Warsaw
See details and how to joinNCT07682883Registry updated 2026-07-06
Phase 3RecruitingTrial-stage medicine
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Where
- Bielsko-Biala, Gliwice, Katowice, Koszalin, Olsztyn, Peremyshl, Siedlce, Warsaw
- Age
- 18 years and over
- People
- 864 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06256588EU 2023-508613-17-00Registry updated 2026-05-26
Phase 3RecruitingTrial-stage medicine
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Where
- Bydgoszcz, Gliwice
- Age
- 18 years and over
- People
- 410 worldwide
- Run by
- AVEO Pharmaceuticals, Inc.
See details and how to joinNCT06064877EU 2023-505606-42-00Registry updated 2026-04-09
No phaseNot yet recruitingResearch participation
Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence
- Where
- Warsaw
- Age
- 18 years and over
- People
- 400
- Run by
- Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
See details and how to joinNCT07361666Registry updated 2026-01-23
Phase 3RecruitingTrial-stage medicine
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- Where
- Bydgoszcz, Gliwice, Szczecin, Wroclaw
- Age
- 18 years and over
- People
- 412 worldwide
- Run by
- Rakuten Medical, Inc.
See details and how to joinNCT06699212EU 2025-523017-28-00Registry updated 2025-10-15
No phaseRecruitingResearch participation
The Hypotension Prediction Index in Free Flap Transplant in Head and Neck Surgery.
- Where
- Poznan
- Age
- 18 years and over
- People
- 206
- Run by
- Jakub Szrama
See details and how to joinNCT05738603Registry updated 2025-08-03
No phaseRecruitingResearch participation
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Gdansk, Warsaw
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767Registry updated 2024-08-26
No phaseRecruitingResearch participation
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
- Where
- Gliwice
- Age
- 18 years to 80 years
- People
- 80
- Run by
- Maria Sklodowska-Curie National Research Institute of Oncology
See details and how to joinNCT06472570Registry updated 2024-06-25
All Head and neck cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.